Viewing data from:

SYNERA

NDA

LIDOCAINE; TETRACAINE | N021623 | GALEN SPECIALTY PHARMA US LLC

1 strength0 unique patents0 unique exclusivities

PTAB Proceedings

No IPR/PGR/CBM challenges found at the Patent Trial and Appeal Board

Patent Reexaminations

No ex parte or inter partes reexamination proceedings found at USPTO

Hatch-Waxman Litigation

No ANDA patent litigation cases (NOS 835) matched from PACER

Citizen Petitions

No FDA citizen petitions matched from Regulations.gov

Clinical Trials

1 trial from ClinicalTrials.gov, 1 completed

Trial	Phase	Status	Sponsor	Enrollment	Dates
The Effect of Topical Anesthetics on Patients' Pain and Operative Experience During Treatment With QSwitched Laser NCT02427724	Early Phase 1	Completed	Northwestern University	48	2015-04 → 2024-05-30

Source: ClinicalTrials.gov. Trials matched by ingredient name.

Approval Letters

5 letters from Drugs@FDA

Source: Drugs@FDA application documents.

Products (1)

#001 — 70MG;70MG

RLD

0 patents0 exclusivities▴

PATCH;TOPICAL | Approved: Jun 23, 2005

No patent or exclusivity listings for this strength.